- €3.27bn
- €7.75bn
- €796.98m
- 78
- 51
- 78
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 367 | 378 | 375 | 422 | 797 |
Cost of Revenue | |||||
Gross Profit | 213 | 237 | 214 | 223 | 432 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21.1 | 390 | 79.1 | 164 | 864 |
Operating Profit | 346 | -12.7 | 296 | 258 | -67.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 350 | -160 | 386 | 186 | -313 |
Provision for Income Taxes | |||||
Net Income After Taxes | 348 | -166 | 346 | 142 | -229 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 359 | -167 | 347 | 143 | -180 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 359 | -167 | 347 | 143 | -180 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.95 | -1.5 | 2.55 | 0.061 | -1.3 |
Dividends per Share |